San Leandro, CA, January 12, 2001--Sepragen Corporation (OTC BB:SPGNA), a
provider of patented technology and equipment for purification needs in the
nutritional and biotech industries, today announced the relocation of its
operations from its Hayward location to nearby San Leandro, California.The new
address and contact information is listed below:
Sepragen
Corporation
14500 Doolittle Drive
San
Leandro, CA 94577
Phone: (510) 667-1004
Fax: (510) 667-1070
Sepragen’s
previous lease had expired. The new
approximately 18,500 sq. ft. facility is comparatively more affordable.
It is better suited to Sepragen’s projected operational needs with a
greater percentage square footage devoted to product manufacturing as opposed to
R & D.
Sepragen is a leading supplier of separation process technology, equipment
and consumables to the biotechnology and nutraceutical industries.
In addition to its biotech drug separation business, the Company has
developed patented applications that provide large market opportunities in the
food and beverage industry, including debittering citrus juices, extracting
isoflavone (plant estrogen) from soy as well as extracting proteins from whey.
The Company holds over 14 issued patents relating to its core technology.
<Back
The statements in this release that relate to future events or
performance, statements about growth, future regulatory clearances, levels of sales and
market size and future manufacturing capacity and efficiencies are forward-looking
statements that involve risks and uncertainties, including risks associated with
uncertainties related to the development of markets for and commercial acceptance of the
company's products and services, the availability of components, competitors' product
introductions and other risks identified in the company's SEC filings. Actual results may
differ from those described in these forward-looking statements. Readers are cautioned not
to place undue reliance on these forward-looking statements, which speak only as of the
date hereof.
|
